These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37923740)

  • 1. Inhibition of LSD1 induces ferroptosis through the ATF4-xCT pathway and shows enhanced anti-tumor effects with ferroptosis inducers in NSCLC.
    Du L; Yang H; Ren Y; Ding Y; Xu Y; Zi X; Liu H; He P
    Cell Death Dis; 2023 Nov; 14(11):716. PubMed ID: 37923740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
    He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
    Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.
    Chen D; Fan Z; Rauh M; Buchfelder M; Eyupoglu IY; Savaskan N
    Oncogene; 2017 Oct; 36(40):5593-5608. PubMed ID: 28553953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC.
    Tang F; Lu C; He X; Lin W; Xie B; Gao X; Peng Y; Yang D; Sun L; Weng L
    Cell Rep; 2023 Dec; 42(12):113477. PubMed ID: 37979167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine-specific demethylase 1 aggravated oxidative stress and ferroptosis induced by renal ischemia and reperfusion injury through activation of TLR4/NOX4 pathway in mice.
    Feng R; Xiong Y; Lei Y; Huang Q; Liu H; Zhao X; Chen Z; Chen H; Liu X; Wang L; Weng X
    J Cell Mol Med; 2022 Aug; 26(15):4254-4267. PubMed ID: 35775122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2).
    Mino K; Nishimura S; Ninomiya S; Tujii H; Matsumori Y; Tsuchida M; Hosoi M; Koseki K; Wada S; Hasegawa M; Sasaki R; Murakami-Yamaguchi Y; Narita H; Suzuki T; Miyata N; Mizukami T
    Biosci Biotechnol Biochem; 2014; 78(6):1010-7. PubMed ID: 25036127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
    Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
    Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
    Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
    El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
    Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11.
    Wang Y; Zhao Y; Wang H; Zhang C; Wang M; Yang Y; Xu X; Hu Z
    FEBS Open Bio; 2020 Apr; 10(4):637-643. PubMed ID: 32107878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
    Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
    Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.
    Augert A; Eastwood E; Ibrahim AH; Wu N; Grunblatt E; Basom R; Liggitt D; Eaton KD; Martins R; Poirier JT; Rudin CM; Milletti F; Cheng WY; Mack F; MacPherson D
    Sci Signal; 2019 Feb; 12(567):. PubMed ID: 30723171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.
    Patrick NM; Griggs CA; Icenogle AL; Gilpatrick MM; Kadiyala V; Jaime-Frias R; Smith CL
    J Steroid Biochem Mol Biol; 2017 Mar; 167():1-13. PubMed ID: 27645313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
    Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
    J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer.
    Li A; Ma T; Wang S; Guo Y; Song Q; Liu H; Yu B; Feng S
    Biomed Pharmacother; 2024 Apr; 173():116240. PubMed ID: 38401512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
    J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
    Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
    Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilocarpine-induced seizures associate with modifications of LSD1/CoREST/HDAC1/2 epigenetic complex and repressive chromatin in mice hippocampus.
    Noches V; Rivera C; González MP; Merello G; Olivares-Costa M; Andrés ME
    Biochem Biophys Rep; 2021 Mar; 25():100889. PubMed ID: 33426312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysine specific demethylase 1 inhibitor alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury.
    Wang X; Sun Y; Fu Y; Wu H; Chen Y; Ye Y; Zhou Q; He L; Zhou E; Wang J; Yang Z
    Eur J Pharmacol; 2022 Oct; 932():175227. PubMed ID: 36007605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response.
    Faletti S; Osti D; Ceccacci E; Richichi C; Costanza B; Nicosia L; Noberini R; Marotta G; Furia L; Faretta MR; Brambillasca S; Quarto M; Bertero L; Boldorini R; Pollo B; Gandini S; Cora D; Minucci S; Mercurio C; Varasi M; Bonaldi T; Pelicci G
    Sci Transl Med; 2021 Dec; 13(623):eabf7036. PubMed ID: 34878824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.